COVID-19 Impact on Vascular Surgery Practice: Experience From an Italian University Regional Hub Center for Vascular Pathology.


Journal

Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 12 10 2020
revised: 20 01 2021
accepted: 21 01 2021
pubmed: 8 2 2021
medline: 12 8 2021
entrez: 7 2 2021
Statut: ppublish

Résumé

The aim of the study is to evaluate the impact of COVID-19 pandemic on vascular surgery practice in a regional hub center for complex vascular disease. This is an observational single-center study in which we collected clinical and surgical data during (P1) and after (P2) the COVID-19 outbreak and the lockdown measures implemented in Northern Italy. We compared those data with the two-month period before the pandemic (P0). Compared to P0, ambulatory activities were severely reduced during P1 and limited to hospitalized patients and outpatients with urgent criteria. We performed 61 operations (18 urgent and 43 elective), with a decrease in both aortic (-17.8%), cerebrovascular (-53.3%), and peripheral artery (-42.6%) disease treatments. We also observed a greater drop in open procedures (-53.2%) than in endovascular ones (-22%). All the elective patients were treated for notdeferrable conditions and they were COVID-19 negative at the ward admission screening; despite this one of them developed COVID19 during the hospital stay. Four COVID-19 positive patients were treated in urgent setting for acute limb ischemia. Throughout P2 we gradually rescheduled elective ambulatory (+155.5%) and surgical (+18%) activities, while remaining substantially lower than during P0 (respectively -45.6% and -25.7%). Despite COVID-19 pandemic, our experience shows that with careful patient's selection, dedicated prehospitalization protocol and proper use of personal protective equipment it is possible to guarantee continuity of care.

Sections du résumé

BACKGROUND BACKGROUND
The aim of the study is to evaluate the impact of COVID-19 pandemic on vascular surgery practice in a regional hub center for complex vascular disease.
METHODS METHODS
This is an observational single-center study in which we collected clinical and surgical data during (P1) and after (P2) the COVID-19 outbreak and the lockdown measures implemented in Northern Italy. We compared those data with the two-month period before the pandemic (P0).
RESULTS RESULTS
Compared to P0, ambulatory activities were severely reduced during P1 and limited to hospitalized patients and outpatients with urgent criteria. We performed 61 operations (18 urgent and 43 elective), with a decrease in both aortic (-17.8%), cerebrovascular (-53.3%), and peripheral artery (-42.6%) disease treatments. We also observed a greater drop in open procedures (-53.2%) than in endovascular ones (-22%). All the elective patients were treated for notdeferrable conditions and they were COVID-19 negative at the ward admission screening; despite this one of them developed COVID19 during the hospital stay. Four COVID-19 positive patients were treated in urgent setting for acute limb ischemia. Throughout P2 we gradually rescheduled elective ambulatory (+155.5%) and surgical (+18%) activities, while remaining substantially lower than during P0 (respectively -45.6% and -25.7%).
CONCLUSIONS CONCLUSIONS
Despite COVID-19 pandemic, our experience shows that with careful patient's selection, dedicated prehospitalization protocol and proper use of personal protective equipment it is possible to guarantee continuity of care.

Identifiants

pubmed: 33549797
pii: S0890-5096(21)00120-5
doi: 10.1016/j.avsg.2021.01.072
pmc: PMC7862030
pii:
doi:

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-79

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

Thromb Haemost. 2020 May;120(5):876-878
pubmed: 32246450
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
Thromb Haemost. 2020 Jun;120(6):949-956
pubmed: 32349133
Eur J Vasc Endovasc Surg. 2020 Jul;60(1):127-134
pubmed: 32499169
JAMA. 2020 Aug 4;324(5):460-470
pubmed: 32492084
Ann Vasc Surg. 2020 Nov;69:90-99
pubmed: 32763457
BMJ. 2020 Jun 10;369:m2195
pubmed: 32522737
Clin Infect Dis. 2020 Dec 3;71(9):2311-2313
pubmed: 32628269
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Vasc Surg. 2020 Dec;72(6):1864-1872
pubmed: 32360679
Lancet Psychiatry. 2020 Mar;7(3):e14
pubmed: 32035030

Auteurs

Gian Antonio Boschetti (GA)

Vascular and Endovascular Surgery Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy; Department of Surgical Sciences and Integrated Diagnostic (DISC), University of Genoa, Genoa, Italy. Electronic address: gianantonioboschetti@gmail.com.

Sara Di Gregorio (S)

Vascular and Endovascular Surgery Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy; Department of Surgical Sciences and Integrated Diagnostic (DISC), University of Genoa, Genoa, Italy.

Jorge Miguel Mena Vera (JM)

Vascular and Endovascular Surgery Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy.

Bianca Pane (B)

Vascular and Endovascular Surgery Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy; Department of Surgical Sciences and Integrated Diagnostic (DISC), University of Genoa, Genoa, Italy.

Giovanni Spinella (G)

Vascular and Endovascular Surgery Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy; Department of Surgical Sciences and Integrated Diagnostic (DISC), University of Genoa, Genoa, Italy.

Domenico Palombo (D)

Vascular and Endovascular Surgery Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy; Department of Surgical Sciences and Integrated Diagnostic (DISC), University of Genoa, Genoa, Italy.

Giovanni Pratesi (G)

Vascular and Endovascular Surgery Unit, Ospedale Policlinico San Martino - IRCCS, Genoa, Italy; Department of Surgical Sciences and Integrated Diagnostic (DISC), University of Genoa, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH